health_en | Page 30 of 128

SIBIONICS to Make Debut at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)

The 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from October 2nd to 6th, 2023, in Hamburg, Germany. Making its debut at this prestigious…

2 ต.ค. 66 15:452023-10-02

thaipr.net

2 ต.ค. 66

China Review Studio and Chinese Red Cross Foundation Release “Generation Vax” Documentary for Broadcast Internationally

The documentary outlines China’s contribution to vaccine science, research, and production since the COVID-19 pandemic and includes a call for science and infectious disease research to be borderless. China Review Studio, in collaboration with Chinese Red Cross Foundation recently released a documentary on YouTube named Generation Vax. Directed by internationally renowned director Mitchell Farkas, the film focuses […]

2 ต.ค. 66 14:00

thaipr.net

2 ต.ค. 66

The 88th CMEF in Shenzhen Set to Spotlight Advancements in the Medical Equipment Industry

The China International Medical Equipment Fair (CMEF), organized by Reed Sinopharm Exhibitions, serves as an excellent bridge for brands aiming to enter the Chinese market. The 88th edition of this…

26 ก.ย. 66 8:08

thaipr.net

26 ก.ย. 66

Pfizer Thailand wins the Gold Level “HR Excellence Awards 2023” for recognition of Excellence in Transforming into a Modern Business.

Pfizer Thailand has been honored with the prestigious Gold Level “HR Excellence Awards 2023” for demonstrating exceptional excellence in transforming modern businesses and organizations.…

25 ก.ย. 66 17:212023-09-25

thaipr.net

25 ก.ย. 66

“Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery”

On September 15, “Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery” successfully kicked off. This marks the first time in recent years that the Company has organized an event specifically focused on pharmaceutical R&D innovation. The forum focused on LNP- and extracellular vesicle-based drug delivery systems covering topics such as development trend, clinical research, […]

25 ก.ย. 66 14:572023-09-25

thaipr.net

25 ก.ย. 66

BDMS Wellness Clinic Partners with “Mövenpick BDMS Wellness Resort” to Tap Into the Wellness Tourism Market

BDMS Wellness Clinic Partners with “Mövenpick BDMS Wellness Resort” to Tap Into the Wellness Tourism Market, Providing Health Programs to Cater to the Global Wellness Tourism Trend of 20% Annual…

25 ก.ย. 66 13:572023-09-25

thaipr.net

25 ก.ย. 66

The Thailanders Best Medical Skin and Wellness 2023 for Charity

A bilingual media The Thailanders, led by its editor- in- chief Amornsiri Boonyasit recently collaborated with Chef Cares Foundation, Revomed Thailand and Facebook page Skininskin to organize…

25 ก.ย. 66 13:44

thaipr.net

25 ก.ย. 66

‘Bayer For Her’ Supporting 365 Days Conversations of Care to More Women in Asia

Bayer Pharmaceuticals Division in Asia/Pacific announced today in conjunction with World Contraception Day, the inception of its ‘Bayer For Her’ regional campaign that has been piloted…

25 ก.ย. 66 10:342023-09-25

thaipr.net

25 ก.ย. 66

BRACCO IMAGING S.p.A. ANNOUNCES GLOBAL AGREEMENT WITH SUBTLE MEDICAL, Inc.

Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Subtle Medical, Inc., a leading innovator in artificial intelligence (AI)-powered image acquisition, have entered into a global agreement in the field of magnetic resonance imaging (MRI). This global agreement will begin primarily in the […]

22 ก.ย. 66 8:30

thaipr.net

22 ก.ย. 66

European Commission Approves Menarini Group’s ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, announced today that the European Commission has approved ORSERDU® (elacestrant) as a monotherapy for the treatment of postmenopausal women, and men, with estrogen receptor (ER)–positive, HER2-negative, locally advanced or metastatic…

22 ก.ย. 66 8:00

thaipr.net

22 ก.ย. 66